Navigation Links
Pradaxa Side Effect Warning: Pradaxa Label to Warn Blood-Thinner Shouldn’t be Used in People with Mechanical Heart Valves, Bernstein Liebhard LLP Reports

New York, NY (PRWEB) December 22, 2012

A new Pradaxa side effect warning has been announced by Boehringer Ingelheim, the maker of the blood thinner, Bernstein Liebhard LLP reports. According to an alert issued by U.S. Food & Drug Administration (FDA) on December 19th, the company will be modifying the Pradaxa label to warn that it should not be prescribed to patients who have had a mechanical prosthetic heart valve replacement. Boehringer Ingelheim will also be sending a “Dear Doctor Letter” to healthcare providers to inform them of this new contraindication. The change follows the halt of RE-ALIGN trial, which was ended because Pradaxa users were more likely to experience strokes, heart attacks, and blood clots forming on the mechanical heart valves than were users of warfarin. There was also more bleeding after valve surgery in the Pradaxa users than in the warfarin users, the FDA said.

“This new contraindication is just another reminder that Pradaxa side effects, including internal bleeding, can be quite serious,” says Bernstein Liebhard LLP, a national law firm representing clients who have been injured by dangerous drugs and defective medical devices. The firm is currently offering free and confidential Pradaxa lawsuit evaluations to patients who were allegedly harmed by this drug.

Pradaxa Lawsuits
Pradaxa is used to prevent strokes in people with a heart-rhythm disorder known as atrial fibrillation. According to a recent report from, internal bleeding is a potential Pradaxa side effect for which there is no readily available antidote. The FDA received reports of 542 deaths and 3,781 side-effect incidents tied to the drug in 2011. Bloomberg also reported that the Institute of Safe Medication Practices has found Pradaxa has generated more reports of injury or death than any of the 800 drugs it monitors.

According to Bloomberg, 150 Pradaxa lawsuits are now pending in a federal multidistrict litigation currently underway in U.S. District Court, Southern District of Illinois. All of the complaints allege plaintiffs suffered serious, life-threatening episodes of internal bleeding, and that the company sold the blood thinner despite knowing it could cause fatal bleeding in some patients. (In Re: Pradaxa (Dabigatran Etexilate) Products Liability Litigation – MDL No. 2385)

Victims of serious Pradaxa side effects may be eligible to collect compensation for their medical bills, lost wages, pain and suffering and more. To learn more about filing a Pradaxa lawsuit, please visit our website, or call 1-877-779-1414 to speak with one of our attorneys today.

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.

10 East 40th Street
New York, New York 10016
(877) 779-1414

ATTORNEY ADVERTISING. © 2012 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. The lawyer responsible for this advertisement in the State of Connecticut is Amy L. Abate. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Approval of Safer Alternative to Pradaxa Delayed by FDA
2. Pradaxa Maker Working on Antidote Amid Pradaxa Bleeding Warnings
3. FDA: Dont Use Pradaxa Blood Thinner in Patients With Artificial Heart Valves
4. Young girls more likely to report side effects after HPV vaccine
5. Preteens More Likely to Report HPV Vaccine Side Effects
6. In children born with severe heart defect, surgical management has little effect on neuro outcomes
7. Novel compound demonstrates anti-leukemic effect in zebrafish, shows promise for human treatment
8. Breast cancer patients suffer treatment-related side effects long after completing care
9. Breast Cancer Treatment Side Effects May Last for Years
10. Baldness Drug May Cause Sexual Side Effects: FDA
11. Study examines adverse effects among different radiation therapies for prostate cancer
Post Your Comments:
(Date:12/1/2015)... ... December 01, 2015 , ... The Multiple System Atrophy ... and funds for Multiple System Atrophy (MSA) research, timed today to coincide with Giving ... things from patients including their ability to work and be productive, to do simple ...
(Date:12/1/2015)... ... 2015 , ... Henderson, a town of about 6,300 people, ... a partnership this year with Aeneas Internet and Telephone. , With faster Internet ... entrepreneurs who want to build a business. Whether startups or long established companies, ...
(Date:12/1/2015)... ... ... Integrated Rental Services (“Integrated Rental”), a growing medical equipment ... With support from JII, Integrated Rental is poised for expansion while improving its ... labs and medical facilities across the United States. , General Manager Robert Bean ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... and hematology continuing medical education (CME), today announced that the first annual School ... New York. , “The prevention, detection and treatment of gastrointestinal cancers are undergoing ...
(Date:12/1/2015)... ... , ... Dr. Paul Vitenas, one of the top cosmetic surgeons in ... as the Best Single Physician Practice in the nation. Dr. Vitenas and his practice ... by the industry publication. , Dr. Vitenas said he was very honored to ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... , Dec. 01, 2015 ... the "Veterinary Equipment and Disposables Market by ... report to their offering. --> ... "Veterinary Equipment and Disposables Market by product, ... report to their offering. --> Research ...
(Date:12/1/2015)... 2015 CytRx Corporation (NASDAQ: CYTR ), ... today announced that it has reached its enrollment target ... 3 clinical trial of aldoxorubicin in patients with previously ... be completed in Q1 2016. The Phase 3 trial is ... Protocol Assessment from the FDA at 79 sites in ...
(Date:12/1/2015)... , Dec. 1, 2015  InCarda Therapeutics, Inc. (InCarda), ... commercialization of therapies for cardiovascular conditions via the inhalation ... business in Australia . InCarda is ... Australia in the first half ... and medical centers in Adelaide ...
Breaking Medicine Technology: